Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential

M Yuan, B Yang, G Rothschild, JJ Mann… - Signal transduction and …, 2023 - nature.com
Major depressive disorder (MDD) is a chronic, generally episodic and debilitating disease
that affects an estimated 300 million people worldwide, but its pathogenesis is poorly …

Genetics factors in major depression disease

M Shadrina, EA Bondarenko, PA Slominsky - Frontiers in psychiatry, 2018 - frontiersin.org
Depressive disorders (DDs) are one of the most widespread forms of psychiatric pathology.
According to the World Health Organization, about 350 million people in the world are …

Cell type specific transcriptomic differences in depression show similar patterns between males and females but implicate distinct cell types and genes

M Maitra, H Mitsuhashi, R Rahimian, A Chawla… - Nature …, 2023 - nature.com
Major depressive disorder (MDD) is a common, heterogenous, and potentially serious
psychiatric illness. Diverse brain cell types have been implicated in MDD etiology …

Epigenetics and depression

S Penner-Goeke, EB Binder - Dialogues in clinical neuroscience, 2019 - Taylor & Francis
The risk for major depression is both genetically and environmentally determined. It has
been proposed that epigenetic mechanisms could mediate the lasting increases in …

Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways

B Devlin, JR Kelsoe, P Sklar, MJ Daly… - Nature …, 2015 - nature.com
Genome-wide association studies (GWAS) of psychiatric disorders have identified multiple
genetic associations with such disorders, but better methods are needed to derive the …

Epigenetic basis of mental illness

EJ Nestler, CJ Peña, M Kundakovic… - The …, 2016 - journals.sagepub.com
Psychiatric disorders are complex multifactorial illnesses involving chronic alterations in
neural circuit structure and function as well as likely abnormalities in glial cells. While …

Cannabidiol as a potential treatment for anxiety and mood disorders: molecular targets and epigenetic insights from preclinical research

PA Melas, M Scherma, W Fratta, C Cifani… - International journal of …, 2021 - mdpi.com
Cannabidiol (CBD) is the most abundant non-psychoactive component of cannabis; it
displays a very low affinity for cannabinoid receptors, facilitates endocannabinoid signaling …

Epigenetic signaling in psychiatric disorders: stress and depression

RC Bagot, B Labonté, CJ Peña… - Dialogues in clinical …, 2014 - Taylor & Francis
Psychiatric disorders are complex multifactorial disorders involving chronic alterations in
neural circuit structure and function. While genetic factors play a role in the etiology of …

Are the epigenetic changes predictive of therapeutic efficacy for psychiatric disorders? A translational approach towards novel drug targets

V Micale, M Di Bartolomeo, S Di Martino, T Stark… - Pharmacology & …, 2023 - Elsevier
The etiopathogenesis of mental disorders is not fully understood and accumulating evidence
support that clinical symptomatology cannot be assigned to a single gene mutation, but it …

The role of synapsins in neurological disorders

FJ Mirza, S Zahid - Neuroscience bulletin, 2018 - Springer
Synapsins serve as flagships among the presynaptic proteins due to their abundance on
synaptic vesicles and contribution to synaptic communication. Several studies have …